Status:
TERMINATED
Treating Tuberculosis Wasting With a High-protein Supplement
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Bandim Health Project
Arla Foods
Conditions:
Tuberculosis
Tuberculosis, Pulmonary
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Undernutrition at the time of diagnosis of active tuberculosis is a risk factor for increased mortality, and lack of weight gain during anti-tuberculous treatment has been linked to an increased relap...
Detailed Description
It is hypothesized that patients with tuberculosis receiving whey protein concentrate as nutritional supplement will experience a greater gain in adverse anthropometric measures, and experience a decr...
Eligibility Criteria
Inclusion
- Patients diagnosed with TB
- Aged 18 years and above
- BMI\<20
Exclusion
- Pregnancy
- Commencement of treatment ≥30 days prior to inclusion
- Decreased kidney function
- Missing informed consent
- Mentally ill/disabled patients unable to comply with the treatment/intervention regimen
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT03302949
Start Date
August 1 2017
End Date
January 30 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Bandim Health Project
Bissau, Denmark, Guinea-Bissau, 1004